Catherine Smith

33.9k total citations · 1 hit paper
362 papers, 14.2k citations indexed

About

Catherine Smith is a scholar working on Immunology, Dermatology and Molecular Biology. According to data from OpenAlex, Catherine Smith has authored 362 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Immunology, 102 papers in Dermatology and 46 papers in Molecular Biology. Recurrent topics in Catherine Smith's work include Psoriasis: Treatment and Pathogenesis (128 papers), Dermatology and Skin Diseases (92 papers) and Asthma and respiratory diseases (30 papers). Catherine Smith is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (128 papers), Dermatology and Skin Diseases (92 papers) and Asthma and respiratory diseases (30 papers). Catherine Smith collaborates with scholars based in United Kingdom, United States and Canada. Catherine Smith's co-authors include Juliet N. Barker, A. David Burden, Richard B. Warren, C.E.M. Griffiths, A. J. Moe, Barry Halliwell, Nick J. Reynolds, Larry Johnson, Nancy J. Cox and M Landt and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Catherine Smith

341 papers receiving 13.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

2017 344 citations Catherine Smith et al. British Journal of Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Smith United Kingdom	67	5.9k	4.1k	2.4k	1.9k	1.9k	362	14.2k
Michael P. Schön Germany	65	6.9k 1.2×	3.3k 0.8×	4.2k 1.7×	4.1k 2.1×	4.9k 2.5×	462	19.7k
Marı́a José Torres Spain	68	1.9k 0.3×	4.8k 1.2×	883 0.4×	4.6k 2.3×	1.2k 0.6×	478	16.8k
Carl Grünfeld United States	94	3.7k 0.6×	1.0k 0.2×	6.8k 2.8×	5.0k 2.6×	7.6k 3.9×	370	31.2k
Hong Wang United States	80	4.1k 0.7×	534 0.1×	2.6k 1.1×	1.7k 0.9×	9.9k 5.1×	749	25.2k
Peter C. Heinrich Germany	75	9.6k 1.6×	635 0.2×	3.4k 1.4×	1.9k 1.0×	9.4k 4.8×	368	27.7k
Harry van Goor Netherlands	73	2.9k 0.5×	353 0.1×	1.9k 0.8×	2.2k 1.1×	5.3k 2.7×	626	27.0k
Steven B. Abramson United States	89	4.6k 0.8×	500 0.1×	1.5k 0.6×	3.6k 1.9×	7.7k 4.0×	309	29.9k
Jürgen Schölmerich Germany	85	5.1k 0.9×	491 0.1×	10.4k 4.3×	3.0k 1.5×	5.5k 2.8×	561	29.1k
Pio Conti Italy	48	3.4k 0.6×	649 0.2×	757 0.3×	1.7k 0.9×	2.1k 1.1×	271	10.0k
Claude Libert Belgium	73	5.0k 0.8×	429 0.1×	2.4k 1.0×	1.7k 0.9×	6.8k 3.5×	266	17.8k

Countries citing papers authored by Catherine Smith

Since Specialization

Citations

This map shows the geographic impact of Catherine Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Smith more than expected).

Fields of papers citing papers by Catherine Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Smith. The network helps show where Catherine Smith may publish in the future.

Co-authorship network of co-authors of Catherine Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Smith. A scholar is included among the top collaborators of Catherine Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Smith. Catherine Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Al‐Janabi, Ali, Paul Martin, Catherine Simpson, et al.. (2025). Blood Single-Cell Transcriptomic and Proteomic Signatures of Paradoxical Eczema in Patients with Psoriasis Treated with Biologics. Journal of Investigative Dermatology. 145(10). 2535–2548. 1 indexed citations

Ramessur, Ravi, Jake Saklatvala, Mari Løset, et al.. (2025). Investigating the Genetic Basis of the Influence of Adiposity on Psoriasis: A Cross-Sectional Study in a Large United Kingdom Population–Based Biobank. Journal of Investigative Dermatology. 145(11). 2891–2895.e12. 2 indexed citations

Tosi, Isabella, Sang Hyuck Lee, Raymond T. Chung, et al.. (2025). Genetic Risk Factors in Childhood Psoriasis. Journal of Investigative Dermatology. 145(9). 2340–2344.e4.

Henderson, Alasdair, Joseph Hayes, Alex Lewin, et al.. (2024). Ethnic differences in depression and anxiety among adults with atopic eczema: Population‐based matched cohort studies within UK primary care. Clinical and Translational Allergy. 14(3). e12348–e12348. 1 indexed citations

Kim, Byung Jin, Wei Tan, Teresa Tsakok, et al.. (2023). Systematic review of deep learning image analyses for the diagnosis and monitoring of skin disease. npj Digital Medicine. 6(1). 180–180. 42 indexed citations

Raharja, Antony, Giulia Rinaldi, Teresa Tsakok, et al.. (2023). Real-World Implementation and Outcomes of Adalimumab Therapeutic Drug Monitoring in Psoriasis: A National Specialized Center Experience. Journal of Investigative Dermatology. 143(9). 1708–1716.e4. 3 indexed citations

Henderson, Alasdair, Ketaki Bhate, Joseph Hayes, et al.. (2023). Severe Mental Illness Among Adults with Atopic Eczema or Psoriasis: Population-Based Matched Cohort Studies within UK Primary Care. Clinical Epidemiology. Volume 15. 363–374. 5 indexed citations

Mitchell, Brittany L., Jake Saklatvala, Nick Dand, et al.. (2022). Genome-wide association meta-analysis identifies 29 new acne susceptibility loci. Nature Communications. 13(1). 702–702. 27 indexed citations

Cro, Suzie, Victoria Cornelius, Francesca Capon, et al.. (2022). The interleukin 1 receptor antagonist anakinra to reduce disease severity of palmoplantar pustulosis in adults: APRICOT RCT and PLUM mechanistic study. SHILAP Revista de lepidopterología. 9(2). 1–106. 1 indexed citations

10.

Tucker, Laura, Alexander Allen, David Chandler, et al.. (2022). The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Lara D. Veeken. 61(9). e255–e266. 9 indexed citations

11.

Mahil, Satveer K., Nina Wilson, Nick Dand, et al.. (2019). Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR ). British Journal of Dermatology. 182(5). 1158–1166. 88 indexed citations

12.

Dawson, Erica D., et al.. (2019). FluChip‐8G Insight: HA and NA subtyping of potentially pandemic influenza A viruses in a single assay. Influenza and Other Respiratory Viruses. 14(1). 55–60. 2 indexed citations

13.

Jabbar‐Lopez, Zarif K., Zenas Z N Yiu, L.S. Exton, et al.. (2017). Re: Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis. Journal of Investigative Dermatology. 137(12). 2644–2646. 6 indexed citations

14.

Jackson, Karina, Richard Groves, Catherine Smith, & Juliet N. Barker. (2009). Inpatient care for psoriasis: a retrospective study of inpatient admission data and the impact of new management modalities in psoriasis. British Journal of Dermatology. 161. 28–29. 1 indexed citations

15.

Warren, Richard B., Emanuela Campalani, Stephen Eyre, et al.. (2008). Genetic Variation in Efflux Transporters Influences Outcome to Methotrexate Therapy in Patients with Psoriasis. Journal of Investigative Dermatology. 128(8). 1925–1929. 100 indexed citations

16.

Warren, Richard B., Rhodri Smith, Emanuela Campalani, et al.. (2007). Genetic variation across the methotrexate metabolic pathway and its influence upon treatment outcomes in patients with psoriasis.. British Journal of Dermatology. 157. 2–3. 4 indexed citations

17.

Smith, Catherine, Karina Jackson, Amparo Sancho Pérez, et al.. (2006). Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study. British Journal of Dermatology. 155(1). 160–169. 44 indexed citations

18.

Smith, Catherine. (2002). A grumphie in the sty: an archaeological of pigs in Scotland, from their earliest domestication to the agricultural revolution. Proceedings of the Society of Antiquaries of Scotland. 130. 705–724. 1 indexed citations

19.

Valkema, Roelf, François Jamar, Stanislas Pauwels, et al.. (2001). Safety and efficacy of [Y-90-DOTA,Tyr(3)]-octreotide (Y-90-SMT487; OctreoTher) peptide receptor radionuclide therapy (PRRT). Preliminary results of a phase-1 study. European Journal of Nuclear Medicine and Molecular Imaging. 28(8). 1025–1025. 10 indexed citations

20.

Smith, Catherine, Edward T. Habermann, & David Hamerman. (1979). A technique for investigating the antigenicity of cultured rheumatoid synovial cells.. PubMed. 6(2). 147–55. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact